Clozapine-Associated Cytomegalovirus Colitis and Related Critical Illness in a Patient With Neither Neutropenia Nor Agranulocytosis

Abstract

Get full access to this article

View all access options for this article.

References

Verbeeck

Berk

Clozapine-associated neutropenia and cytomegalovirus colitis. Pharmacopsychiatry. 1998;31:236-237. doi:10.1055/s-2007-979335

Leung

Nelson

Takala

Gören

JL.

Infection and inflammation leading to clozapine toxicity and intensive care: a case series. Ann Pharmacother. 2014;48:801-805. doi:10.1177/1060028014526701

Naranjo

Busto

Sellers

et al . A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. doi:10.1038/clpt.1981.154

Horn

Hansten

Chan

LN.

Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674-680. doi:10.1345/aph.1H423

Goodman

Murray

Watkins

Griffiths

Webster

DP.

CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis. Eur J Clin Microbiol Infect Dis. 2015;34:13-18. doi:10.1007/s10096-014-2212-x

Klenerman

Oxenius

T cell responses to cytomegalovirus. Nat Rev Immunol. 2016;16:367-377. doi:10.1038/nri.2016.38